Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia
about
sameAs
Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsIn vivo therapeutic gas delivery for neuroprotection with echogenic liposomes.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.The neurotrophic and neuroprotective effects of psychotropic agents.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Chronic lithium feeding reduces upregulated brain arachidonic acid metabolism in HIV-1 transgenic rat.Targeting the glutamatergic system to develop novel, improved therapeutics for mood disordersNeuroprotection in the newborn infantCombined prostaglandin E1 and lithium exert potent neuroprotection in a rat model of cerebral ischemiaA new neurological focus in neonatal intensive care.Fyn in Neurodevelopment and Ischemic Brain Injury.Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular ActionsThe Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter.Chronic lithium chloride administration attenuates brain NMDA receptor-initiated signaling via arachidonic acid in unanesthetized rats.From direct to indirect lithium targets: a comprehensive review of omics data.Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2.Time course of acute neuroprotective effects of lithium carbonate evaluated by brain impedanciometry in the global ischemia model.Excitatory and inhibitory synaptic dysfunction in mania: an emerging hypothesis from animal model studies.
P2860
Q24626017-C49E85FC-1DEE-41F1-8906-D810478469B9Q24651407-97D41551-78AC-4D57-AAC5-8397517BCCCFQ26741164-536983BA-0A96-4E85-93D3-00CD8BEE5D12Q30473667-89D368BC-4CBC-47F8-A49F-0EA0B64A5470Q33284843-FCE75FE3-F374-48E2-8DA8-E9312488C7B6Q33566724-E5B19E10-6775-44D0-858C-9924F2C01F9CQ33583992-FBAD119A-7FAC-4F93-A465-E331195CA2D4Q34766451-C0AC78C6-7C83-4EFF-9F85-AFB21AFAC680Q34974649-97B11420-E71F-4D4B-A34A-ADA2C04CED3EQ35154467-227DF528-CD19-4726-98B7-0491D404838CQ35197096-967F9D16-B1CB-477E-B522-7A41D996C1FDQ35212429-BBFE70F7-0E07-4022-B178-797F685AE972Q36338186-16DFF7A4-E1BF-4C3C-9251-C9C3372D8C99Q37143117-BD02AE1F-9DA2-4EB4-91EF-9CF023217D42Q37452432-3BBFDC63-FB20-48CD-8B0D-25BC83E60AA8Q37728835-328ADFA6-DA4B-4395-A247-9BD365BE25EDQ37909914-192F83DA-52D9-4808-9394-DDDA3BAFFB7CQ38365592-BFA1CF05-0F61-4710-89EE-F1D2539319BBQ38770806-0B75B87E-29E0-45CA-B51E-368A3249A0B9Q39094792-E4920B05-ABD9-4865-B8F0-D6D10D8D045BQ46808102-54544D0D-8DC1-4B7A-9680-0094681FCB5EQ47779120-BB97F402-5170-4E76-A784-515FFE841297Q48146045-3185858F-CB77-44B2-BE6E-94645C6F9B4DQ48897639-CABAA5DE-6F15-404D-8F0D-EC053A2A0E58Q52328697-46BEF949-39D4-4822-9548-4905EE4CF306
P2860
Lithium reduced N-methyl-D-aspartate receptor subunit 2A tyrosine phosphorylation and its interactions with Src and Fyn mediated by PSD-95 in rat hippocampus following cerebral ischemia
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@ast
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@en
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@nl
type
label
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@ast
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@en
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@nl
prefLabel
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@ast
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@en
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@nl
P3181
P1433
P1476
Lithium reduced N-methyl-D-asp ...... us following cerebral ischemia
@en
P2093
Guang-Yi Zhang
P3181
P356
10.1016/S0304-3940(03)00784-5
P407
P577
2003-09-18T00:00:00Z